SANTA CLARA, Calif. - Agilent Technologies Inc. (NYSE:A), a $35 billion market cap company with a "GOOD" financial health rating according to InvestingPro, has released a new line of high performance ...

Collaboration combines Lunit's AI expertise with Agilent's diagnostic leadership to revolutionize biomarker testing and enhance precision medicine capabilities SEOUL, South Korea, Sept. 22, 2025 ...

A recap of the morning session focused on method development, from Day 2 of HPLC 2025. Method development in LC remains a complex, expertise-heavy process, but emerging AI tools offer new promise for ...

1 General Department of Forensic Science and Criminology, Dubai Police GHQ, Dubai, United Arab Emirates 2 Department of Chemistry, College of Sciences, United Arabs Emirates University, Al Ain, United ...

Cancer is a common cause of death in both developed and developing countries (Jemal et al., 2011). Hepatocellular carcinoma (HCC) is the fifth most prevalent cancer worldwide, and it represents the ...

To enhance the efficiency of the analytical method development process, Almac Sciences worked in collaboration with S-Matrix to test the Fusion QbD® software platform. Optimisation of a peptide and ...

A novel HPLC method was developed and validated for the determination of D-Carnitine in Levocarnitine in accordance with the ICH Q2R1 guidelines. The method demonstrated system precision, specificity, ...

Interactive website for validation of analytical methods, offering statistical tools for evaluating selectivity, linearity, detection and quantification limits, and linearity tests.

Elevating lab efficiency with enhanced automation, connectivity, and sustainability capabilities SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced the release ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the release of its next generation Agilent InfinityLab LC Series portfolio, which includes the 1290 Infinity ...

In this article, we review some key considerations for chromatographic technique selection and method development across the full drug process. Selection of the correct analytical technique from the ...